22-05-2024 14:36 via rocketnews.com

Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront

Biogen Inc. said Wednesday it’s acquiring privately held Human Immunology Biosciences for $1.15 billion upfront and up to $650 million in potential milestone payments in a move aimed at bolstering its immunology portfolio.
Article Attribution | Read More at Article Source
[mwai_chat context=”Let’s have a discussion about this article:nnBiogen Inc. said Wednesday it’s acquiring privately held Human Immunology Biosciences for $1.15 billion upfront and up to $650 million in

Happy Eid al-Adha 2024!

‘We get a raw deal’: This was my worst Father’s Day of all time — and it had nothing to do with a ‘crummy’ tie or tickets to see Taylor Swift

These stock sectors have fallen so much they now look attractive, analyst says

‘We get a raw deal’: On Father’s Day, here’s the worst thing you can do — and it doesn’t involve giving your dad a ‘crummy’ tie or tickets to see Taylor Swift

What Wells Fargo’s ‘mouse-jiggler’ scandal says about the problem with work right now

Oil scores biggest weekly gain since early April

Goolsbee is thrilled by low inflation readings but says Fed needs more proof that prices are easing

French banking-sector bonds buckle as Paris awaits snap elections

Bond market’s rally may have more room to run: ‘What a week it’s been’

Hurco’s stock slides 5% after company suspends quarterly dividend payments

Range bar charts: how to use them in Forex trading

Mester says Fed needs to see more low inflation readings before cutting interest rates

Steelmaker Nucor’s stock extends selloff after a profit warning

Desktop versie

Biogen to acquire privately held Human Immunology Biosciences for $1.15 billion upfront

Analyst news